首页> 外国专利> CACNB2 nucleic acid mutations as indicators of shorter than normal QT interval and ST segment elevation associated with sudden cardiac death

CACNB2 nucleic acid mutations as indicators of shorter than normal QT interval and ST segment elevation associated with sudden cardiac death

机译:CACNB2核酸突变是短于正常QT间隔和ST段抬高与心脏猝死相关的指标

摘要

Previously unknown mutations of the CACNA1C and CACNB2b genes are disclosed which are involved in ion channel disruptions associated with shorter than normal QT interval and ST segment elevation syndrome. These mutations are utilized to diagnose and screen for shorter than normal QT interval and ST segment elevation syndrome, thus providing modalities for diagnosing syncope and/or sudden cardiac death and/or predicting susceptibility to syncope and/or sudden cardiac death. Nucleic acid probes are provided which selectively hybridize to the mutant nucleic acids described herein. Antibodies are provided which selectively bind to the mutant polypeptides described herein. The mutations described herein are also utilized to screen for compounds useful in treating the symptoms manifest by such mutations.
机译:公开了以前未知的CACNA1C和CACNB2b基因突变,这些突变与短于正常QT间隔和ST段抬高综合征相关的离子通道破坏有关。这些突变被用于诊断和筛查比正常的QT间隔和ST段抬高综合征短的时间,从而为诊断晕厥和/或猝死性心脏病和/或预测晕厥和/或猝死性心脏病的易感性提供了方法。提供了与本文所述突变核酸选择性杂交的核酸探针。提供了与本文所述的突变多肽选择性结合的抗体。本文所述的突变还用于筛选可用于治疗由此类突变表现出的症状的化合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号